Georges Benarroch insider trades: Kyto Technology & Life Science (KBPH) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Georges reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 22, 2009 | KBPH | ↑ Buy | 133,333 | $0.45 | $60K | Direct | Jan 11, 2010 (20d) |
| Dec 22, 2009 | GLLA | ↑ Buy | 310,000 | $0.07 | $22K | Direct | Jan 11, 2010 (20d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Georges Benarroch's insider trades
Georges Benarroch is a director at Kyto Technology & Life Science (KBPH). Since Dec 22, 2009, Georges has reported 2 open-market purchases worth $82K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings), other transactions (4 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KBPH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.